Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

• URL: http://arxiv.org/abs/2211.05235v1
• Date: Fri, 28 Oct 2022 03:39:55 GMT
• Title: Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding
• Authors: Jianfeng Wu (1), Yi Su (2), Wenhui Zhu (1), Negar Jalili Mallak (1), Natasha Lepore (3), Eric M. Reiman (2), Richard J. Caselli (4), Paul M. Thompson (5), Kewei Chen (2), Yalin Wang (1) (for the Alzheimer's Disease Neuroimaging Initiative, (1) School of Computing and Augmented Intelligence, Arizona State University, Tempe, USA, (2) Banner Alzheimer's Institute, Phoenix, USA, (3) CIBORG Lab, Department of Radiology Children's Hospital Los Angeles, Los Angeles, USA, (4) Department of Neurology, Mayo Clinic Arizona, Scottsdale, USA, (5) Imaging Genetics Center, Stevens Neuroimaging and Informatics Institute, University of Southern California, Marina del Rey, USA)
• Abstract summary: We develop a non-invasive framework to quantitatively predict the amyloid and tau measurements. We evaluate our framework on amyloid PET/MRI and tau PET/MRI datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Background: Beta-amyloid (A$\beta$) plaques and tau protein tangles in the brain are the defining 'A' and 'T' hallmarks of Alzheimer's disease (AD), and together with structural atrophy detectable on brain magnetic resonance imaging (MRI) scans as one of the neurodegenerative ('N') biomarkers comprise the ''ATN framework'' of AD. Current methods to detect A$\beta$/tau pathology include cerebrospinal fluid (CSF; invasive), positron emission tomography (PET; costly and not widely available), and blood-based biomarkers (BBBM; promising but mainly still in development). Objective: To develop a non-invasive and widely available structural MRI-based framework to quantitatively predict the amyloid and tau measurements. Methods: With MRI-based hippocampal multivariate morphometry statistics (MMS) features, we apply our Patch Analysis-based Surface Correntropy-induced Sparse coding and max-pooling (PASCS-MP) method combined with the ridge regression model to individual amyloid/tau measure prediction. Results: We evaluate our framework on amyloid PET/MRI and tau PET/MRI datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Each subject has one pair consisting of a PET image and MRI scan, collected at about the same time. Experimental results suggest that amyloid/tau measurements predicted with our PASCP-MP representations are closer to the real values than the measures derived from other approaches, such as hippocampal surface area, volume, and shape morphometry features based on spherical harmonics (SPHARM). Conclusion: The MMS-based PASCP-MP is an efficient tool that can bridge hippocampal atrophy with amyloid and tau pathology and thus help assess disease burden, progression, and treatment effects.

Related papers

• GFE-Mamba: Mamba-based AD Multi-modal Progression Assessment via Generative Feature Extraction from MCI [5.355943545567233]
  Alzheimer's Disease (AD) is an irreversible neurodegenerative disorder that often progresses from Mild Cognitive Impairment (MCI) We introduce GFE-Mamba, a classifier based on Generative Feature Extraction (GFE) It integrates data from assessment scales, MRI, and PET, enabling deeper multimodal fusion. Our experimental results demonstrate that the GFE-Mamba model is effective in predicting the conversion from MCI to AD.
  arXiv  Detail & Related papers  (2024-07-22T15:22:33Z)
• Multimodal MRI-based Detection of Amyloid Status in Alzheimer's Disease Continuum [13.220436208437576]
  Amyloid-$beta$ plaques are neuropathological hallmarks of Alzheimer's disease (AD) Deep learning methods relying mainly on amyloid PET images have been employed to this end. We propose a novel multimodal approach that integrates information from structural, functional, and diffusion MRI data to discriminate A$beta$ status in the AD continuum.
  arXiv  Detail & Related papers  (2024-06-19T07:51:21Z)
• A Demographic-Conditioned Variational Autoencoder for fMRI Distribution Sampling and Removal of Confounds [49.34500499203579]
  We create a variational autoencoder (VAE)-based model, DemoVAE, to decorrelate fMRI features from demographics. We generate high-quality synthetic fMRI data based on user-supplied demographics.
  arXiv  Detail & Related papers  (2024-05-13T17:49:20Z)
• Three-Dimensional Amyloid-Beta PET Synthesis from Structural MRI with Conditional Generative Adversarial Networks [45.426889188365685]
  Alzheimer's Disease hallmarks include amyloid-beta deposits and brain atrophy. PET is expensive, invasive and exposes patients to ionizing radiation. MRI is cheaper, non-invasive, and free from ionizing radiation but limited to measuring brain atrophy.
  arXiv  Detail & Related papers  (2024-05-03T14:10:29Z)
• Amyloid-Beta Axial Plane PET Synthesis from Structural MRI: An Image Translation Approach for Screening Alzheimer's Disease [49.62561299282114]
  An image translation model is implemented to produce synthetic amyloid-beta PET images from structural MRI that are quantitatively accurate. We found that the synthetic PET images could be produced with a high degree of similarity to truth in terms of shape, contrast and overall high SSIM and PSNR.
  arXiv  Detail & Related papers  (2023-09-01T16:26:42Z)
• A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry [18.36168858563601]
  Alzheimer's Disease (AD) is the most common type of age-related dementia, affecting 6.2 million people aged 65 or older according to CDC data. It is commonly agreed that discovering an effective AD diagnosis biomarker could have enormous public health benefits.
  arXiv  Detail & Related papers  (2023-03-31T21:17:54Z)
• Breast Cancer Induced Bone Osteolysis Prediction Using Temporal Variational Auto-Encoders [65.95959936242993]
  We develop a deep learning framework that can accurately predict and visualize the progression of osteolytic bone lesions. It will assist in planning and evaluating treatment strategies to prevent skeletal related events (SREs) in breast cancer patients.
  arXiv  Detail & Related papers  (2022-03-20T21:00:10Z)
• Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy [18.81651314175103]
  One of the hallmarks of Alzheimer's disease (AD) is the accumulation of tau plaques in the human brain. Current methods to detect tau pathology are either invasive (lumbar puncture) or quite costly and not widely available (Tau PET)
  arXiv  Detail & Related papers  (2021-10-20T18:05:33Z)
• Hippocampus segmentation in magnetic resonance images of Alzheimer's patients using Deep machine learning [0.0]
  The aim of this study was the segmentation of the hippocampus in magnetic resonance (MR) images of Alzheimers patients using deep machine learning method. The proposed approach is promising and can be extended in the prognosis of Alzheimers disease by the prediction of the hippocampus volume changes in the early stage of the disease.
  arXiv  Detail & Related papers  (2021-06-12T11:00:29Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)
• Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using Deep Multiple-Instance Learning [59.74684475991192]
  Parkinson's Disease (PD) is a slowly evolving neuro-logical disease that affects about 1% of the population above 60 years old. PD symptoms include tremor, rigidity and braykinesia. We present a method for automatically identifying tremorous episodes related to PD, based on IMU signals captured via a smartphone device.
  arXiv  Detail & Related papers  (2020-05-06T09:02:30Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.